Molecular imprint of lung cancer development
Sam Janes (London, United Kingdom)
|  |
CREB signaling in KRAS-driven lung adenocarcinoma
Georgia Giotopoulou (Patras, Greece)
| |
Downregulation of the pro-apototic gene, BNIPL, in bronchial biopsies from COPD patients
Karl J. Staples (Southampton, United Kingdom)
| |
Lung stem cells and lung cancer
Carla Kim (Boston, USA)
| |
A critical role for mTOR regulated metabolic reprogramming during TGF-? induced fibroblast collagen synthesis
Brintha Selvarajah (London, United Kingdom)
| |
Deregulated SOX2 drives a migratory signature in a novel organotypic model of bronchial dysplasia
Lucia Correia (Cambridge, United Kingdom)
|  |
Lung repair and disease
Georgios Stathopoulos (Munich, Germany)
| |
Nontypeable Haemophilus influenzae-promoted proliferation of K-ras-induced early lung cancer lesions is completely dependent on Toll-like receptor signaling
Christoph Beisswenger (Homburg, Germany)
| |
Myeloid NF-?B signaling fosters KRAS-mutant tumors
Magda Spella (Patras, Greece)
| |
Dendritic cells, immunomodulation, COPD, and cancer
Karim Vermaelen (Ghent, Belgium)
| |
Poster Session 1
Darcy Wagner (Munich, Germany), Henna Karvonen (Toronto, Canada), Claire Rooney (London, United Kingdom), Argyris Tzouvelekis (Athens, Greece), Toby Mellows (Southmapton, United Kingdom), Khondoker Akram (London, United Kingdom), Felix Ritzmann (Homburg, Germany), Didier Cataldo (Liege, Belgium), Amy Adlard (Manchester, United Kingdom), Iciar P. Lopez (Logroño, Spain), Christoph Beisswenger (Homburg, Germany), Phil Barry (Cambridge, United Kingdom), John-Poul Ng-Blichfeldt (Groningen, Netherlands), Plamen Minkov (Stara Zagora, Bulgaria), Mareike Lehmann (Munich, Germany), Laura Succony (London, United Kingdom), Songmin Ying (Hangzhou, China), Eleftheri Letsiou (Berlin, Germany), Tiziana Patrizia Cremona (Bern, Switzerland), Jamil Jubrail (Paris, France), Eva Maria Garrido-Martin (Southampton, United Kingdom), Sebastian Marwitz (Borstel, Germany), Rajesh Jagirdar (Larissa, Greece), Tiziana Patrizia), Rebecca Delaney (Belfast, United Kingdom), Aaron Scott (Birmingham, United Kingdom), Isaac Almendros (Barcelona, Spain), Marielle Breau (Cretiel, France), Ellen Forty (London, United Kingdom), Giulia Stella (Pavia, Italy), Kaustav Chakraborty (Kolkata, India), Jessica D Eley (London, United Kingdom), Catharina Mueller (Lund, Sweden), Chiara De Santi (Dublin, Ireland), Vanessa Welk (Munich, Germany), Mathew Eapen (Hobart, Australia), Mathew Eapen (Hobart, Australia)
| |
FGFs in lung disease
Saverio Bellusci (Giessen, Germany)
| |
Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Doherty Declan (Belfast, United Kingdom)
| |
Circulating fibrocytes depletion results in reduced lung tumor growth and metastasis by modulating macrophage phenotype, angiogenesis and endothelin system
Rajkumar Savai (Bad Nauheim, Germany)
| |
EMT in development and disease
Angela Nieto (Alicante, Spain)
| |
KRAS & TP53 mutations cause malignant mesothelioma
Anthi Krontira (Patras, Greece)
| |
Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer
Xiang Zheng (Bad Nauheim, Germany)
| |
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Nikolaos Kanellakis (Patras, Greece)
| |
Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD)
Amal Houssaini (Munich, Germany)
| |
The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Gizem Gunes (Munich, Germany)
| |
Poster Session 2
Manuela Platé (London, United Kingdom), Argyris Tzouvelekis (Athens, Greece), Lara Buhl (Munich, Germany), Rahul Mahida (Birmingham, United Kingdom), Manosij Ghosh (Leuven Belgium), Tanya Tacheva (Stara Zagora, Bulgaria), Grace Cooper (Southampton, United Kingdom), Aron Ghimessy (Budapest, Hungary), Darcy Wagner (Munich, Germany), Changhui Wang (Shanghai, China), Julie Laval (Tuebingen, Germany), Elizabeth Sage (London, United Kingdom), Tiziana Patrizia Cremona (Bern, Switzerland), Tankut G. Guney (London, United Kingdom), Elise De Smet (Ghent, Belgium), Jan Willem Duitman (Paris, France), Christoph Mayr (Munich, Germany), Ieva Janulaityte (Kaunas, Luthania), Maria Ester Quesada del Bosque (Southampton, United Kingdom), Adam Szpechcinski (Warsaw, Poland), Lorena Giuranno (Maastricht, Netherlands), Kate Gowers (London, United Kingdom), Sergio Piñeiro-Hermida (Logroño, Spain), Poonam Sarode (Bad Nauheim, Germany), Ioannis Morianos Athens (Greece), Ken Bracke (Ghent, Belgium), Ioannis Psallidas (Oxford, United Kingdom), Soumya Chatterjee (Kolkata, India), Casper Wahlund (Stockholm, Sweden), Maximilian Strunz (Munich, Germany), Carmen Veith (Maastricht, Netherlands), Joana Alçada (London, United Kingdom), Alexandra Schröder (Borstel, Germany), Michela Terlizzi (Salerno, Italy), Joshua Wallington (Southampton, United Kingdom), Mariangela Natale (Coimbra, Portugal)
| |
ERS and EU Funding opportunities
Rory Morty (Giessen, Germany)
| |
ERC Grants
Stathopoulos Georgios (Munich Germany)
| |
Funding opportunities focused on flexible research careers
Janette K. Burgess (Groningen, Netherlands)
| |
How to write a successful funding application?
Melanie Königshoff (Denver, USA)
| |
Immune checkpoint and COPD
Tom Wilkinson (Southampton, United Kingdom)
| |
ER stress in chronic lung disease
Stefan Marciniak (Cambridge, United Kingdom)
| |
Dissecting chronic lung disease
Richard Marshall (Stevenage, United Kingdom)
| |
Cell therapy for lung disease
Felix Hermann (Munich, Germany)
| |